Skip to content
Sign up to receive our free weekday morning edition, and you'll never miss a scoop.
U.S. House Speaker Kevin McCarthy (R-CA)

McCarthy’s new gig: Watchtower Strategy

Former Speaker Kevin McCarthy is launching a new public affairs firm with five close political allies, an entity that is sure to become an instant player in corporate circles.

McCarthy, Jeff Miller, Dan Conston, Arthur Schwartz, Cliff Sims and Brian O. Walsh are launching Watchtower Strategy. McCarthy will chair the firm and Conston, the longtime former president of the Congressional Leadership Fund, will be the CEO.

Miller is the founder of Miller Strategies and arguably the GOP’s top fundraiser. Schwartz, a close ally of Vice President JD Vance and political adviser to Donald Trump Jr., just finished running the confirmation process for Defense Secretary Pete Hegseth. Sims worked in the first Trump administration as deputy director of national intelligence and helped run John Ratcliffe’s confirmation as CIA director. And Walsh is a GOP ad maker who ran America First and CLF.

Watchtower Strategy aims to specialize in strategy, which includes C-suite consulting and corporate political positioning, crisis communications and advocacy campaigns.

As evidenced by last week, corporations could have a rough go of it during President Donald Trump’s tenure in the White House. And public affairs firms will be in high demand.

Watchtower has experience on Capitol Hill (McCarthy and Conston), the administration (Sims), media (Schwartz) and campaigns (Walsh).

McCarthy also serves on several corporate boards: C3 AI and Anivive Lifesciences.

The firm won’t be engaged in any lobbying.

Presented by AstraZeneca

The 340B program was created to help patients. Instead, it’s helping hospitals earn massive profits. The 340B Rebate Model Pilot uses rapid verification of existing data to prevent duplicate discounts, strengthening program transparency and efficiency. Urge HHS to implement the Rebate Model Pilot and ensure 340B functions as intended. Get the facts.

Editorial photos provided by Getty Images. Political ads courtesy of AdImpact.

Presented by AstraZeneca

The 340B program is supposed to help vulnerable patients—but without strong safeguards, it’s siphoning away funds that could be used for free and charitable medicine. The 340B Rebate Model Pilot improves program integrity, preventing duplicate discounts and strengthening accountability. Urge HHS to implement the pilot today. Learn why it matters.

Welcome to Punchbowl News AM! We're glad to have you here.

Want to get more of what you need? Share a bit more about yourself to help us tailor your reader experience.

Thank you for signing up!

Thank you for signing up!

 

We have sent you a confirmation email. Please follow the provided instructions to complete your sign-up.

Thank you for confirming! You are now subscribed to the Punchbowl News AM list.

You're subscribed! Welcome to the community.